Literature DB >> 9215641

Spatial and temporal expression of the 72-kDa type IV collagenase (MMP-2) correlates with development and differentiation of valves in the embryonic avian heart.

S M Alexander1, K J Jackson, K M Bushnell, P G McGuire.   

Abstract

Extracellular proteases may play an important role in the regulation of cell migration and remodeling of the extracellular matrix during development. In this study, we have examined the embryonic avian heart for the expression of matrix metalloproteases. The 72-kDa type IV collagenase, MMP-2, was detected in extracts of whole hearts and showed a modest increase in amount over time. This increase in enzyme activity corresponded to a small increase in the steady-state level of mRNA for this enzyme. A more dramatic increase was seen in the amount of the 66-kDa activated form of this enzyme as development progressed, suggesting that the process of activation, rather than enzyme synthesis, may be the important regulatory step in this system. Coincident with the change in the level of active MMP-2 was a significant increase in the expression of the MMP-2 activator, MT-MMP, between stages 12 and 24. The message for MMP-2 was expressed by the endocardium of the cushion tissues which was undergoing an epithelial-mesenchymal transition, and by the migrating mesenchymal cells, suggesting a role for this protease in regulating cell motility and matrix invasion. In older staged hearts, the cells of the differentiating valves expressed high levels of MMP-2 which may be important for the final remodeling events in this region.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215641     DOI: 10.1002/(SICI)1097-0177(199707)209:3<261::AID-AJA2>3.0.CO;2-G

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  15 in total

Review 1.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

3.  Versican proteolysis mediates myocardial regression during outflow tract development.

Authors:  Christine B Kern; Russell A Norris; Robert P Thompson; W Scott Argraves; Sarah E Fairey; Leticia Reyes; Stanley Hoffman; Roger R Markwald; Corey H Mjaatvedt
Journal:  Dev Dyn       Date:  2007-03       Impact factor: 3.780

4.  AP-1 (Fra-1/c-Jun)-mediated induction of expression of matrix metalloproteinase-2 is required for 15S-hydroxyeicosatetraenoic acid-induced angiogenesis.

Authors:  Nikhlesh K Singh; Dong Van Quyen; Venkatesh Kundumani-Sridharan; Peter C Brooks; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

5.  Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure.

Authors:  Srikanth Givvimani; Charu Munjal; Riyad Gargoum; Utpal Sen; Neetu Tyagi; Jonathan C Vacek; Suresh C Tyagi
Journal:  J Appl Physiol (1985)       Date:  2011-01-13

6.  Arsenic exposure perturbs epithelial-mesenchymal cell transition and gene expression in a collagen gel assay.

Authors:  Alejandro Lencinas; Derrick M Broka; Jay H Konieczka; Scott E Klewer; Parker B Antin; Todd D Camenisch; Raymond B Runyan
Journal:  Toxicol Sci       Date:  2010-03-22       Impact factor: 4.849

7.  Monocytes and Macrophages in Heart Valves: Uninvited Guests or Critical Performers?

Authors:  Sridhar Sraeyes; Duc H Pham; Terence W Gee; Joanna Hua; Jonathan T Butcher
Journal:  Curr Opin Biomed Eng       Date:  2018-03-05

Review 8.  Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-05       Impact factor: 2.673

Review 9.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure.

Authors:  S Givvimani; S Kundu; N Narayanan; F Armaghan; N Qipshidze; S Pushpakumar; T P Vacek; S C Tyagi
Journal:  Arch Physiol Biochem       Date:  2013-02-11       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.